S2Medical AB (S2M) - Total Liabilities

Latest as of December 2025: Skr6.90 Million SEK ≈ $742.44K USD

Based on the latest financial reports, S2Medical AB (S2M) has total liabilities worth Skr6.90 Million SEK (≈ $742.44K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

S2Medical AB - Total Liabilities Trend (2015–2025)

This chart illustrates how S2Medical AB's total liabilities have evolved over time, based on quarterly financial data. See working capital position of S2Medical AB to evaluate short-term liquidity relative to the company's equity base.

S2Medical AB Competitors by Total Liabilities

The table below lists competitors of S2Medical AB ranked by their total liabilities.

Company Country Total Liabilities
Kermode Resources Ltd
V:KLM
Canada CA$255.54K
Zinnwald Lithium PLC
LSE:ZNWD
UK GBX2.20 Million
MAPLE LEAF GREEN WORLD
F:4HV0
Germany €8.29 Million
TrustBIX Inc
V:TBIX
Canada CA$3.35 Million
Gelion PLC
LSE:GELN
UK GBX1.54 Million
EPWK Holdings Ltd. Class A Ordinary Shares
NASDAQ:EPWK
USA $12.19 Million
Venus Concept Inc
NASDAQ:VERO
USA $58.49 Million
Redan S.A.
WAR:RDN
Poland zł34.54 Million

Liability Composition Analysis (2015–2025)

This chart breaks down S2Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see S2Medical AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.70 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how S2Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for S2Medical AB (2015–2025)

The table below shows the annual total liabilities of S2Medical AB from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Skr6.90 Million
≈ $742.44K
+9.73%
2024-12-31 Skr6.29 Million
≈ $676.58K
-68.17%
2023-12-31 Skr19.75 Million
≈ $2.13 Million
+8.36%
2022-12-31 Skr18.22 Million
≈ $1.96 Million
+21.54%
2021-12-31 Skr15.00 Million
≈ $1.61 Million
+76.90%
2020-12-31 Skr8.48 Million
≈ $912.24K
+51.40%
2019-12-31 Skr5.60 Million
≈ $602.53K
+1.21%
2018-12-31 Skr5.53 Million
≈ $595.34K
+45.66%
2017-12-31 Skr3.80 Million
≈ $408.73K
+3.35%
2016-12-31 Skr3.67 Million
≈ $395.49K
+6.24%
2015-12-31 Skr3.46 Million
≈ $372.24K
--

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$502.89K
Skr4.67 Million SEK
Market Cap Rank
#30854 Global
#730 in Sweden
Share Price
Skr0.01
Change (1 day)
-3.70%
52-Week Range
Skr0.00 - Skr0.02
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more